UBE2V1 and COVID-19: On the other hand, a preprint study of Chinese patients with COVID-19 reported that TMEM189-UBE2V1, involved in the IL-1 signaling pathway, and the HLA-A*11:01, -B*51:01 and -C*14:02 alleles were significantly associated with severe disease or worse outcome [42].